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Objectives
Recent studies have highlighted the prevalence of stressful and traumatic life events within individuals diagnosed with a psychotic disorder (Grubaugh et al., 2011) . The prevalence of posttraumatic stress disorder (PTSD) as a co-morbid condition within this group has been estimated to be 12.4% (Achim et al., 2011) . These studies have facilitated our understanding of psychotic symptoms within the context of traumatic events (e.g. Longden et al., 2012; Steel et al., 2005) and in the development of trauma-focused treatments for this population (Frueh et al., 2009; van den Berg et al., 2015) . Epidemiological findings and therapeutic developments have contributed to recent calls for more trauma-informed mental health services (Rose et al., 2012) , including the routine assessment of trauma history and current symptoms of posttraumatic stress. There is, therefore, a need for a brief screening instrument to identify those requiring trauma focussed interventions.
Self-report measures of PTSD have acceptable psychometrics, in comparison to standardised interviews, within non-psychotic populations and can be used in routine clinical practice (Brewin, 2005) . However, potential limitations include respondents misunderstanding items and not discriminating accurately between PTSD symptoms and other difficulties (McDonald & Calhoun, 2010) . These limitations may be particularly marked in the context of psychosis. There is considerable overlap between symptoms of psychosis and PTSD, with sensory-perceptual intrusions, hyperarousal, avoidance and dissociation common in both groups. During assessment, additional prompts may be needed to distinguish them from each other (Gearon et al., 2004) . Even with prompting, respondents with psychosis may find it difficult to identify symptoms as being temporally anchored to a specific traumatic event. Further, the content of psychotic symptoms can be of such a threat so as to constitute a traumatic event itself (Berry et al., 2013) . Assessment for the symptoms of post-psychotic PTSD requires careful discrimination from other current symptoms of psychosis, which is not addressed in current self-report measures of PTSD.
The Posttraumatic Checklist (PCL; (PCL; Weathers et al., 1993) is a widely used self-report screening assessment of PTSD. However, there are no reports assessing its reliability in people with psychosis. Mueser et al. (2001) found moderate to high convergent reliability of the PCL and Clinician Administer PTSD Scale (CAPS) in a sample (n = 30) with severe mental illness. However, only 27% of their sample had a diagnosis of schizophrenia. The current study reports data from a randomised controlled trial where a PCL cut-off score of 44 is used to indicate more detailed assessment through clinical interview. Previous research has shown the PCL to be 80% predictive of diagnostic status when using a threshold of 44 in individuals who have suffered a road traffic accident (Blanchard et al., 1996) . The design of the parent study required that individuals who scored below PCL cut-off did not undergo further trauma assessment. Therefore, whilst this study is the first to explore the utility of the PCL in identifying PTSD within individuals diagnosed with a psychotic disorder, we limit our focus to the rate of false positives rather than false negatives.
Material and Methods

Participants
The current data was obtained as part of recruitment for a randomised controlled trial aimed at evaluating cognitive behaviour therapy as a treatment for the symptoms of posttraumatic distress within individuals diagnosed with a psychotic disorder (ISRCTN67096137).
Inclusion criteria were a current DSM-IV (APA, 1994) diagnosis of schizophrenia, schizoaffective disorder or schizophreniform disorder, being aged between 18 and 65, able to speak English and having stable living arrangements. Two-hundred and nine individuals provided informed consent to participate in the clinical trial, of whom 165 provided complete data sets in relation to assessment of traumatic symptoms.
Measures
Posttraumatic Stress Disorder Checklist (PCL; Blanchard et al., 1996) . PCL part I was used to assess the prevalence of a range of traumatic life events. The original 16 items were extended to include two extra items relevant to the current population. Namely, the experience of threatening psychiatric treatment and the experiences of threatening psychotic experiences (Picken & Tarrier, 2011) . Part II of the PCL contains 17 items on a 5-point scale (range 17-85) as brief measure of posttraumatic stress symptoms.
Clinician Administered PTSD Scale for Schizophrenia (CAPS-S; Gearon et al., 2004) . The CAPS is a widely used clinical interview based on the DSM diagnostic criteria for PTSD.
The CAPS-S is an adapted form of the CAPS (Blake et al., 1995) in which language has been amended for the target population.
Procedure
Participants first completed PCL part I where they reported which of the 18 stressful life events they had experienced, followed by identifying which of these events was causing them the most current distress. Part II of the PCL was then completed in relation to this item.
If a participant scored 44 or above on part II of the PCL, further assessment was conducted using the CAPS-S.
Results
The 165 participants included 118 (71.5%) males and 47 (28.5%) females, and had a mean age of 41.85 (SD=10.05). The primary diagnosis was schizophrenia for 137 (83.0%) participants and schizoaffective disorder for 28 (17.0%). Eighty (48.5%) participants lived alone, 54 (32.7%) with a partner or family and 31 (18.7%) in shared or temporary accommodation. Ethnicity was stated as White 112 (67.9%), Black Carribbean 6 (3.6%), Black African 8 (4.8%), Indian 10 (6.1%), Pakistani 6 (3.6%), Bangladeshi 3 (1.8%), Chinese 1 (0.6%) and Other 16 (9.7%).
The assessment of trauma prevalence and the currently most distressing event is presented in Table 1 . The mean number of stressful life events identified was 5.7 (SD=2.9, range = 1 to 15).
---------------------------Insert Table 1 About Here ------------------------------
One hundred and one participants (61.2%) scored 44 or above on part II of the PCL in relation to their currently most distressing event, with the mean total being 49.6 (SD=17.1, range = 17 to 85). Of these 101, 30 (18.2% of the total sample) were rated as suffering from a diagnostic level of PTSD based on the CAPS-S assessment. Therefore, only 29.7% of the sample identified by using the PCL with this cut-off score were diagnostic of PTSD, with 70.3% being 'false positives' When the cut-off score on the PCL was raised to 50 or above, 81 (49.1% of the total sample) participants were included. Of these 81, 28 (16.9% of the total sample) were rated as suffering from a diagnostic level of PTSD based on the CAPS-S assessment. Therefore, only 34.6% of the sample identified by using the PCL with this cut-off score were diagnostic of PTSD, with 65.4% being 'false positives'. The total PCL score was significantly correlated with the total CAPS-S score (rs = 0.40, p<0.01)
Discussion
We identified 18.2% of our sample as exhibiting diagnostic levels of PTSD when using the PCL with a cut-off score of 44, followed by further assessment with CAPS-S. However, if we had adopted a cut-off of 44 on the PCL alone as a diagnostic indicator, 61.2% of the sample would have been deemed to suffer from PTSD. This figure drops to 49.1% when using a PCL cut-off score of 50. Our results clearly indicate a large, and clinically unacceptable, number of false positives to occur when using this brief trauma screen to assess posttraumatic symptoms in a sample of people diagnosed with a psychotic disorder.
The fact that the CAPS-S is based on clinical interview and not self-report is likely to be relevant. Further, anecdotal reports from those conducting the assessments suggest respondents found it difficult to distinguish their psychotic and PTSD symptoms, particularly in relation to psychosis-related traumas.
A clear limitation of the current study is that not all participants were assessed using the CAPS-S. Thus, we do not have complete data on false negatives. That is, there are likely to have been individuals scoring under 44 on the PCL who were exhibiting diagnostic levels of PTSD. Within the psychiatric system this would result in individuals requiring a trauma treatment being missed. However, this group is likely to be small given that only two participants from one-hundred and sixty-five scored between 44 and 50 on the PCL and subsequently revealed diagnostic levels of PTSD. Further, the clinical utility of the use of the PCL within this population is highly questionable based on the data from false positives alone.
Our results have clear implications for the assessment of traumatic symptoms for the purpose of planning interventions within the psychiatric system. The CAPS-S is a detailed clinical interview which requires extensive training for those delivering it, and is unlikely to be widely adopted within routine clinical services. However, although further evaluation of the PCL is required in order to determine sensitivity and specificity, our findings suggest that the PCL is not recommended as a screening tool for PTSD within people diagnosed with a psychotic disorder. Other measures, such as the Trauma Screening Questionnaire (Brewin et al., 2002; de Bont et al 2015) may enable clearer distinction between the self-report of the symptoms associated with PTSD and those associated with a diagnosis of schizophrenia.
Key Points
 There have been recent calls for trauma-informed mental health services, including routine assessment of the symptoms of posttraumatic stress disorder in individuals diagnosed with a psychotic disorder.
 Assessment of PTSD within those who have suffered a psychotic episode requires careful distinction between the symptoms of the two disorders.
 The PCL is a convenient self-report measure of trauma symptoms. However, our findings indicate that this instrument is not recommended as a screening tool for PTSD within individuals diagnosed with psychotic disorders.
 Future research should aim to understand why self-report measures are not a valid diagnostic measure of PTSD for this group.
 Based on this understanding, there is the need to develop a brief assessment of PTSD for use in clinical practice.
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